Sunshine Biopharma Up Premarket After Steep Fall; Traders Track $6M Filing
Sunshine Biopharma shares pointed higher in premarket Monday, bouncing after a selloff Friday. Traders looked at a new $6 million share-and-warrant registration and noted the latest quarterly loss.